Unknown

Dataset Information

0

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).


ABSTRACT: Diagnosis of B-cell chronic lymphocytic leukemia (B-CLL) is usually straightforward, involving clinical, immunophenotypic (Matutes score), and (immuno)genetic analyses (to refine patient prognosis for treatment). CLL cases with atypical presentation (e.g., Matutes ≤ 3) are also encountered, and for these diseases, biology and prognostic impact are less clear. Here we report the genomic characterization of a case of atypical B-CLL in a 70-yr-old male patient; B-CLL cells showed a Matutes score of 3, chromosomal translocation t(14;18)(q32;q21) (BCL2/IGH), mutated IGHV, deletion 17p, and mutations in BCL2, NOTCH1 (subclonal), and TP53 (subclonal). Quite strikingly, a novel PAX5 mutation that was predicted to be loss of function was also seen. Exome sequencing identified, in addition, a potentially actionable BRAF mutation, together with novel somatic mutations affecting the homeobox transcription factor NKX2-3, known to control B-lymphocyte development and homing, and the epigenetic regulator LRIF1, which is implicated in chromatin compaction and gene silencing. Neither NKX2-3 nor LRIF1 mutations, predicted to be loss of function, have previously been reported in B-CLL. Sequencing confirmed the presence of these mutations together with BCL2, NOTCH1, and BRAF mutations, with the t(14;18)(q32;q21) translocation, in the initial diagnostic sample obtained 12 yr prior. This is suggestive of a role for these novel mutations in B-CLL initiation and stable clonal evolution, including upon treatment withdrawal. This case extends the spectrum of atypical B-CLL with t(14;18)(q32;q21) and highlights the value of more global precision genomics for patient follow-up and treatment in these patients.

SUBMITTER: Burlet B 

PROVIDER: S-EPMC7903887 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).

Burlet Bénédicte B   Ramla Selim S   Fournier Cyril C   Abrey-Recalde Maria Jimena MJ   Sauter Camille C   Chrétien Marie-Lorraine ML   Rossi Cédric C   Duffourd Yannis Y   Ragot Sylviane S   Buriller Céline C   Tournier Benjamin B   Chapusot Caroline C   Nadal Nathalie N   Racine Jessica J   Guy Julien J   Bailly François F   Martin Laurent L   Casasnovas Olivier O   Bastie Jean-Noël JN   Caillot Denis D   Albuisson Juliette J   Broccardo Cyril C   Thieblemont Catherine C   Delva Laurent L   Maynadié Marc M   Aucagne Romain R   Callanan Mary B MB  

Cold Spring Harbor molecular case studies 20210219 1


Diagnosis of B-cell chronic lymphocytic leukemia (B-CLL) is usually straightforward, involving clinical, immunophenotypic (Matutes score), and (immuno)genetic analyses (to refine patient prognosis for treatment). CLL cases with atypical presentation (e.g., Matutes ≤ 3) are also encountered, and for these diseases, biology and prognostic impact are less clear. Here we report the genomic characterization of a case of atypical B-CLL in a 70-yr-old male patient; B-CLL cells showed a Matutes score of  ...[more]

Similar Datasets

| S-EPMC6408174 | biostudies-literature
| S-EPMC10296542 | biostudies-literature
| S-EPMC9898723 | biostudies-literature
| S-EPMC10162861 | biostudies-literature
| S-EPMC8566464 | biostudies-literature
| S-EPMC5372601 | biostudies-literature
| S-EPMC2835495 | biostudies-literature
| S-EPMC5964290 | biostudies-literature
| S-EPMC7427996 | biostudies-literature
| S-EPMC7307282 | biostudies-literature